Stem Cell Radiotherapy and Temozolomide for Newly Diagnosed High-grade Glioma
Clinical trial NCT02039778 · TERMINATED
Trial details
- NCT number
- NCT02039778
- Sponsor
- Beth Israel Medical Center
- Status
- TERMINATED
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2013-12-01
- Primary completion
- 2015-12-01
- Enrollment
- 4
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.